Advertisement

Latest News

APPLAUSE-IgAN: Iptacopan (Fabhalta) Exhibits 49.3% Slower eGFR Decline in IgAN Patients Than Placebo

17 minutes ago

2-year results from phase 3 APPLAUSE-IgAN demonstrate slower eGFR decline, reduced composite kidney failure, and proteinuria in IgAN patients treated with iptacopan.

Recognizing and Classifying Obstructive Hypertrophic Cardiomyopathy

1 hour ago

Panelists discuss the signs, symptoms, diagnostic delays, and classification of obstructive hypertrophic cardiomyopathy, including how it differs from other forms and its implications for clinical management.

Diagnosing Hypertrophic Cardiomyopathy: Challenges and Gaps in Clinical Practice

1 hour ago

Panelists discuss the challenges and gaps in diagnosing hypertrophic cardiomyopathy, including variability in clinical practice, underdiagnosis, and opportunities to improve detection.

Intravenous Iron — When to Escalate, Formulation Choice, and Safety Considerations

9 hours ago

Learn when to switch to IV iron, which formulations need fewer infusions, and how to manage rare reactions, MRI issues, and hypophosphatemia.

Q1 2026 Recap: Pulmonology News and Updates

11 hours ago

The Q1 recap for pulmonology spotlights regulatory and clinical advances across asthma and pulmonary fibrosis.

Advertisement
Advertisement